Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Hossam El Benawi: Who Can Safely Stop Anticoagulation after LVT Resolution?
Hossam El Benawi/LinkedIn
Jun 17, 2026, 20:06

Hossam El Benawi: Who Can Safely Stop Anticoagulation after LVT Resolution?

Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:

”Who Might Need Long-Term Anticoagulation After Left Ventricular Thrombus (LVT) Resolution

Much on the optimal anticoagulant for LVT resolution.

However, less is known about management after LVT resolution:

Clinical factors associated with LVT recurrence?

Echo findings predict recurrence?

Should predictors be assessed at the time of LVT diagnosis or resolution?

Most importantly?!!!!: Who can safely STOP AC after LVT resolution?

Our Mayo Clinic multi-site study (Part 2) showed that:

Among 252 patients with LVT resolution, recurrence occurred in (14.3%).

Patients with recurrent LVT were likely to have:

  • Ischemic cardiomyopathy (83.3% vs 61.1%, p=0.01)
  • Lower LVEF at time of LVT resolution (34.0% ± 12.4 vs 40.0% ± 15.3, p=0.04)
  • LV apical aneurysm (25.0% vs 6.5%, p=0.005)

Echo at time of LVT resolution more predictive of recurrence than at diagnosis.

Adjusted Cox Analysis

Factors associated with higher risk of recurrence:

  • LV apical aneurysm — HR 3.12 (1.43–6.84)
  • Prior ischemic stroke — HR 2.75 (1.22–6.17)

Factors associated with lower risk of recurrence:

  • Higher LVEF — HR 0.96 per 1% increase (0.95–0.99)
  • Continuation of AC — HR 0.27 (0.13–0.58)

Patients with LV apical aneurysm, prior ischemic stroke, or persistently reduced LVEF benefit from prolonged AC.

The remaining question is:

Who can safely STOP AC after LVT resolution?

Stay tuned for Part 3 of Mayo Clinic multi-site LVT studies, exploring novel bed side score that help to define who can safely STOP AC post resolution?”

Title: Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence

Authors: Kirsten M. Lipps, Hossam Elbenawi, Samuel Heller Jr., Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, David A. Liedl, Raymond C. Shields, Damon E. Houghton

Hossam El Benawi: Who Can Safely Stop Anticoagulation after LVT Resolution?

Stay updated on all scientific advances with Hemostasis Today.

Ana I. Casanegra Anticoagulation Damon E Houghton David A. Liedl Health Hematology Hemostasis Hemostasis News Hemostasis Today Hossam El Benawi Hossam Elbenawi Kirsten M. Lipps Left Ventricular Thrombus LVT Mayo Clinic Medicine Paul W. Wennberg Raymond C. Shields Robert D. McBane Samuel Heller Jr. Stanislav Henkin Thom W. Rooke thrombosis Waldemar E. Wysokinski
NewsFeed